Rank | Gene Set | Z-score |
---|---|---|
1 | glomerular epithelial cell development (GO:0072310) | 9.10765243 |
2 | glomerular basement membrane development (GO:0032836) | 8.02233100 |
3 | regulation of guanylate cyclase activity (GO:0031282) | 7.32967701 |
4 | lipoprotein transport (GO:0042953) | 7.10504442 |
5 | NADH metabolic process (GO:0006734) | 6.97540346 |
6 | fat-soluble vitamin biosynthetic process (GO:0042362) | 6.45464134 |
7 | intestinal cholesterol absorption (GO:0030299) | 6.18914545 |
8 | positive regulation of guanylate cyclase activity (GO:0031284) | 5.83629561 |
9 | intestinal absorption (GO:0050892) | 5.78335013 |
10 | fructose metabolic process (GO:0006000) | 5.65049317 |
11 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.41215372 |
12 | glucuronate metabolic process (GO:0019585) | 5.24194861 |
13 | uronic acid metabolic process (GO:0006063) | 5.24194861 |
14 | adhesion of symbiont to host cell (GO:0044650) | 5.00809612 |
15 | virion attachment to host cell (GO:0019062) | 5.00809612 |
16 | regulation of cellular extravasation (GO:0002691) | 4.96554494 |
17 | drug catabolic process (GO:0042737) | 4.72836575 |
18 | * angiotensin maturation (GO:0002003) | 4.68410155 |
19 | regulation of cGMP biosynthetic process (GO:0030826) | 4.64216518 |
20 | regulation of triglyceride catabolic process (GO:0010896) | 4.42509547 |
21 | receptor guanylyl cyclase signaling pathway (GO:0007168) | 4.40539440 |
22 | regulation of bile acid biosynthetic process (GO:0070857) | 4.39299090 |
23 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 4.38769353 |
24 | L-phenylalanine catabolic process (GO:0006559) | 4.38769353 |
25 | regulation of cholesterol esterification (GO:0010872) | 4.31608209 |
26 | adhesion of symbiont to host (GO:0044406) | 4.29764309 |
27 | L-phenylalanine metabolic process (GO:0006558) | 4.24371821 |
28 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.24371821 |
29 | peptide catabolic process (GO:0043171) | 4.23649539 |
30 | phospholipid efflux (GO:0033700) | 4.22321467 |
31 | negative regulation of cholesterol transport (GO:0032375) | 4.18326003 |
32 | negative regulation of sterol transport (GO:0032372) | 4.18326003 |
33 | urea cycle (GO:0000050) | 4.10040255 |
34 | urea metabolic process (GO:0019627) | 4.10040255 |
35 | high-density lipoprotein particle remodeling (GO:0034375) | 4.07175677 |
36 | digestion (GO:0007586) | 4.04740938 |
37 | cysteine metabolic process (GO:0006534) | 4.04268790 |
38 | renal system process involved in regulation of blood volume (GO:0001977) | 4.03603899 |
39 | * regulation of systemic arterial blood pressure mediated by a chemical signal (GO:0003044) | 4.03475061 |
40 | * endocrine process (GO:0050886) | 4.03475061 |
41 | * regulation of systemic arterial blood pressure by hormone (GO:0001990) | 4.03475061 |
42 | glycolipid catabolic process (GO:0019377) | 4.03459095 |
43 | glycosphingolipid catabolic process (GO:0046479) | 4.01198726 |
44 | alpha-linolenic acid metabolic process (GO:0036109) | 4.00304804 |
45 | positive regulation of p38MAPK cascade (GO:1900745) | 4.00105384 |
46 | regulation of cholesterol homeostasis (GO:2000188) | 3.92458838 |
47 | aromatic amino acid family catabolic process (GO:0009074) | 3.92457849 |
48 | bile acid and bile salt transport (GO:0015721) | 3.92102627 |
49 | plasma lipoprotein particle assembly (GO:0034377) | 3.91738199 |
50 | vitamin A metabolic process (GO:0006776) | 3.91620286 |
51 | cholesterol efflux (GO:0033344) | 3.91554438 |
52 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.90855758 |
53 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.90855758 |
54 | alkaloid metabolic process (GO:0009820) | 3.90381139 |
55 | homocysteine metabolic process (GO:0050667) | 3.88578735 |
56 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 3.87570168 |
57 | regulation of cGMP metabolic process (GO:0030823) | 3.86600024 |
58 | vitamin transport (GO:0051180) | 3.83621974 |
59 | reverse cholesterol transport (GO:0043691) | 3.82640083 |
60 | flavonoid metabolic process (GO:0009812) | 3.82470124 |
61 | vitamin transmembrane transport (GO:0035461) | 3.79363133 |
62 | lipoprotein metabolic process (GO:0042157) | 3.79279049 |
63 | drinking behavior (GO:0042756) | 3.78961059 |
64 | fat-soluble vitamin metabolic process (GO:0006775) | 3.78534974 |
65 | cholesterol homeostasis (GO:0042632) | 3.75286508 |
66 | cellular response to nitric oxide (GO:0071732) | 3.73609740 |
67 | * regulation of systemic arterial blood pressure (GO:0003073) | 3.72681500 |
68 | nitrogen cycle metabolic process (GO:0071941) | 3.71954062 |
69 | sterol homeostasis (GO:0055092) | 3.71367256 |
70 | protein-lipid complex assembly (GO:0065005) | 3.69449386 |
71 | arginine metabolic process (GO:0006525) | 3.69282927 |
72 | drug transmembrane transport (GO:0006855) | 3.68989545 |
73 | lysine catabolic process (GO:0006554) | 3.67341153 |
74 | lysine metabolic process (GO:0006553) | 3.67341153 |
75 | plasma lipoprotein particle remodeling (GO:0034369) | 3.65450448 |
76 | protein-lipid complex remodeling (GO:0034368) | 3.65450448 |
77 | macromolecular complex remodeling (GO:0034367) | 3.65450448 |
78 | regulation of vitamin metabolic process (GO:0030656) | 3.64418453 |
79 | antibacterial humoral response (GO:0019731) | 3.63087017 |
80 | surfactant homeostasis (GO:0043129) | 3.62387597 |
81 | * glomerulus development (GO:0032835) | 3.58273488 |
82 | positive regulation of cGMP biosynthetic process (GO:0030828) | 3.58023700 |
83 | sulfur amino acid catabolic process (GO:0000098) | 3.57592596 |
84 | maintenance of gastrointestinal epithelium (GO:0030277) | 3.55316427 |
85 | glyoxylate metabolic process (GO:0046487) | 3.54944926 |
86 | * peptide hormone processing (GO:0016486) | 3.54449087 |
87 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.52912372 |
88 | phospholipid homeostasis (GO:0055091) | 3.51732015 |
89 | tryptophan catabolic process (GO:0006569) | 3.51059102 |
90 | indole-containing compound catabolic process (GO:0042436) | 3.51059102 |
91 | indolalkylamine catabolic process (GO:0046218) | 3.51059102 |
92 | antimicrobial humoral response (GO:0019730) | 3.50325961 |
93 | triglyceride homeostasis (GO:0070328) | 3.49932431 |
94 | acylglycerol homeostasis (GO:0055090) | 3.49932431 |
95 | positive regulation of glycoprotein biosynthetic process (GO:0010560) | 3.47702905 |
96 | epithelial cell differentiation involved in kidney development (GO:0035850) | 3.47289686 |
97 | glutamine family amino acid biosynthetic process (GO:0009084) | 3.47189752 |
98 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.45525180 |
99 | protein carboxylation (GO:0018214) | 3.45525180 |
100 | vitamin D metabolic process (GO:0042359) | 3.43472796 |
101 | bile acid metabolic process (GO:0008206) | 3.43113493 |
102 | kynurenine metabolic process (GO:0070189) | 3.41958466 |
103 | glycosylceramide metabolic process (GO:0006677) | 3.41581280 |
104 | bile acid biosynthetic process (GO:0006699) | 3.41060900 |
105 | midgut development (GO:0007494) | 3.40798663 |
106 | positive regulation of lipid catabolic process (GO:0050996) | 3.40037636 |
107 | exogenous drug catabolic process (GO:0042738) | 3.39126321 |
108 | omega-hydroxylase P450 pathway (GO:0097267) | 3.38955580 |
109 | cGMP biosynthetic process (GO:0006182) | 3.37366130 |
110 | plasma lipoprotein particle clearance (GO:0034381) | 3.36353313 |
111 | regulation of protein activation cascade (GO:2000257) | 3.35778675 |
112 | amino-acid betaine metabolic process (GO:0006577) | 3.32312164 |
113 | drug transport (GO:0015893) | 3.31917732 |
114 | tryptophan metabolic process (GO:0006568) | 3.30917756 |
115 | hormone catabolic process (GO:0042447) | 3.29129149 |
116 | response to nitric oxide (GO:0071731) | 3.27200207 |
117 | L-ascorbic acid metabolic process (GO:0019852) | 3.26812490 |
118 | vitamin biosynthetic process (GO:0009110) | 3.26713297 |
119 | regulation of complement activation (GO:0030449) | 3.22694633 |
120 | ceramide catabolic process (GO:0046514) | 3.22366550 |
121 | diacylglycerol metabolic process (GO:0046339) | 3.21103007 |
122 | cellular response to reactive nitrogen species (GO:1902170) | 3.20523831 |
123 | drug metabolic process (GO:0017144) | 3.19155132 |
124 | negative regulation of fibrinolysis (GO:0051918) | 3.15598582 |
125 | positive regulation of glycoprotein metabolic process (GO:1903020) | 3.15174410 |
126 | sphingomyelin metabolic process (GO:0006684) | 3.14655310 |
127 | mRNA modification (GO:0016556) | 3.13624841 |
128 | complement activation, alternative pathway (GO:0006957) | 3.13573299 |
129 | cholesterol transport (GO:0030301) | 3.11612871 |
130 | sterol transport (GO:0015918) | 3.11612871 |
131 | cytidine metabolic process (GO:0046087) | 3.11217480 |
132 | cytidine catabolic process (GO:0006216) | 3.11217480 |
133 | cytidine deamination (GO:0009972) | 3.11217480 |
134 | positive regulation of cGMP metabolic process (GO:0030825) | 3.10699315 |
135 | digestive system process (GO:0022600) | 3.10193001 |
136 | positive regulation of pseudopodium assembly (GO:0031274) | 3.08461324 |
137 | cellular glucuronidation (GO:0052695) | 3.07227810 |
138 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 3.06470269 |
139 | glycerol metabolic process (GO:0006071) | 3.06277528 |
140 | cobalamin metabolic process (GO:0009235) | 3.04758363 |
141 | positive regulation of triglyceride metabolic process (GO:0090208) | 3.02333442 |
142 | renal system process involved in regulation of systemic arterial blood pressure (GO:0003071) | 3.01964147 |
143 | sphingolipid catabolic process (GO:0030149) | 3.01658996 |
144 | urate metabolic process (GO:0046415) | 3.00200641 |
145 | plasma lipoprotein particle organization (GO:0071827) | 2.99466421 |
146 | epoxygenase P450 pathway (GO:0019373) | 2.98724089 |
147 | lipid homeostasis (GO:0055088) | 2.98560635 |
148 | serine family amino acid catabolic process (GO:0009071) | 2.97977365 |
149 | modified amino acid transport (GO:0072337) | 2.96924825 |
150 | transcytosis (GO:0045056) | 2.95651118 |
151 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 2.93396905 |
152 | protein-lipid complex subunit organization (GO:0071825) | 2.92477547 |
153 | * regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.90217999 |
154 | fibrinolysis (GO:0042730) | 2.89189421 |
155 | fatty acid beta-oxidation (GO:0006635) | 2.88923867 |
156 | heme transport (GO:0015886) | 2.88082170 |
157 | regulation of fibrinolysis (GO:0051917) | 2.86339790 |
158 | regulation of p38MAPK cascade (GO:1900744) | 2.81818584 |
159 | chemical homeostasis within a tissue (GO:0048875) | 2.80037059 |
160 | aromatic amino acid family metabolic process (GO:0009072) | 2.79942197 |
161 | endothelial cell chemotaxis (GO:0035767) | 2.79439955 |
162 | low-density lipoprotein particle clearance (GO:0034383) | 2.78835987 |
163 | glomerular visceral epithelial cell development (GO:0072015) | 10.3186138 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 7.80819322 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 5.54034923 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.10726072 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 4.64978029 |
5 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.62564773 |
6 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 3.77248202 |
7 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 3.52659963 |
8 | * NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.28176819 |
9 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 3.20358520 |
10 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 3.01072403 |
11 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 2.88699180 |
12 | * CLOCK_20551151_ChIP-Seq_293T_Human | 2.73215569 |
13 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.65112068 |
14 | * CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.52641667 |
15 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 2.31452184 |
16 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 2.29573353 |
17 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 2.09756953 |
18 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.09092831 |
19 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.89970244 |
20 | * GATA4_25053715_ChIP-Seq_YYC3_Human | 1.89526744 |
21 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.87510539 |
22 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.80323272 |
23 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.71149089 |
24 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.69789467 |
25 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.68334680 |
26 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.60772352 |
27 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.59493243 |
28 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.58070740 |
29 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.54991150 |
30 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.48161116 |
31 | * SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.45854620 |
32 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.45455720 |
33 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.43739302 |
34 | GATA6_25053715_ChIP-Seq_YYC3_Human | 1.41634820 |
35 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.40161027 |
36 | GATA1_22025678_ChIP-Seq_K562_Human | 1.39670767 |
37 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.37288081 |
38 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.34861390 |
39 | CDX2_22108803_ChIP-Seq_LS180_Human | 1.34169357 |
40 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.33408042 |
41 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.28757055 |
42 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.25705602 |
43 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.23811083 |
44 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.22953055 |
45 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.19800948 |
46 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.17919105 |
47 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.16177675 |
48 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.14470610 |
49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.12460017 |
50 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.12449376 |
51 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.11308024 |
52 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.11087965 |
53 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.10882710 |
54 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.10159444 |
55 | GATA2_19941826_ChIP-Seq_K562_Human | 1.08771095 |
56 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.07410555 |
57 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.04551517 |
58 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.03385219 |
59 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 1.03143868 |
60 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.02021856 |
61 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.01445813 |
62 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.01073249 |
63 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.00240208 |
64 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.99167683 |
65 | * WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.98484335 |
66 | KLF5_25053715_ChIP-Seq_YYC3_Human | 0.98373831 |
67 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.97958310 |
68 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.97442526 |
69 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.97285893 |
70 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 0.96246084 |
71 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.95861778 |
72 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.93815409 |
73 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.93299389 |
74 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.92953890 |
75 | GATA1_19941826_ChIP-Seq_K562_Human | 0.92766864 |
76 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 0.92709455 |
77 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.92098232 |
78 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90658790 |
79 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90000018 |
80 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.88616431 |
81 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 0.87212517 |
82 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.86363450 |
83 | SA1_27219007_Chip-Seq_Bcells_Human | 0.84330306 |
84 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.84026024 |
85 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.84026024 |
86 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 0.83494677 |
87 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.81268035 |
88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80526340 |
89 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.79524473 |
90 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.78512294 |
91 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.78189483 |
92 | CJUN_26792858_Chip-Seq_BT549_Human | 0.77331746 |
93 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.77244747 |
94 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.76888106 |
95 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.76579181 |
96 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.76578592 |
97 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.76308625 |
98 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.75841034 |
99 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.75693376 |
100 | * PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.75658969 |
101 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.75613284 |
102 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.74747346 |
103 | FOXA1_21572438_ChIP-Seq_LNCaP_Human | 0.74464670 |
104 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.74390944 |
105 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.74372821 |
106 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.74353571 |
107 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.73983769 |
108 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 0.73453408 |
109 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.73059291 |
110 | NANOG_20526341_ChIP-Seq_ESCs_Human | 0.72856468 |
111 | HNFA_21074721_ChIP-Seq_CACO-2_Human | 0.72808721 |
112 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.72487588 |
113 | CBP_21632823_ChIP-Seq_H3396_Human | 0.72137525 |
114 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.72134693 |
115 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.72110312 |
116 | BCOR_27268052_Chip-Seq_Bcells_Human | 0.71397752 |
117 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.71060839 |
118 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.70705491 |
119 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.70537777 |
120 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 0.69468525 |
121 | ATF3_27146783_Chip-Seq_COLON_Human | 0.68188810 |
122 | RXR_22108803_ChIP-Seq_LS180_Human | 0.67883057 |
123 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.67759007 |
124 | FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.65769756 |
125 | KDM2B_26808549_Chip-Seq_K562_Human | 0.64116494 |
126 | * FOXA1_25552417_ChIP-Seq_VCAP_Human | 0.64004406 |
127 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.63718438 |
128 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.63265502 |
129 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.63076197 |
130 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 0.62781918 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0005360_urolithiasis | 8.44083824 |
2 | MP0002139_abnormal_hepatobiliary_system | 6.04159054 |
3 | MP0005085_abnormal_gallbladder_physiolo | 4.79058188 |
4 | MP0005365_abnormal_bile_salt | 4.17413589 |
5 | MP0001666_abnormal_nutrient_absorption | 3.80950958 |
6 | MP0008875_abnormal_xenobiotic_pharmacok | 3.80724952 |
7 | MP0003252_abnormal_bile_duct | 3.60466400 |
8 | MP0009840_abnormal_foam_cell | 3.58105178 |
9 | MP0010329_abnormal_lipoprotein_level | 3.15917052 |
10 | MP0009379_abnormal_foot_pigmentation | 3.08825008 |
11 | MP0005332_abnormal_amino_acid | 2.94868036 |
12 | MP0010155_abnormal_intestine_physiology | 2.31204848 |
13 | MP0010368_abnormal_lymphatic_system | 2.27973157 |
14 | MP0003806_abnormal_nucleotide_metabolis | 2.24405723 |
15 | MP0004019_abnormal_vitamin_homeostasis | 2.22421857 |
16 | MP0009643_abnormal_urine_homeostasis | 2.21645027 |
17 | MP0003191_abnormal_cellular_cholesterol | 2.03934764 |
18 | MP0005409_darkened_coat_color | 1.88776931 |
19 | MP0004272_abnormal_basement_membrane | 1.87642697 |
20 | MP0003705_abnormal_hypodermis_morpholog | 1.87328518 |
21 | MP0001664_abnormal_digestion | 1.80204002 |
22 | MP0002118_abnormal_lipid_homeostasis | 1.80182246 |
23 | MP0000609_abnormal_liver_physiology | 1.64816734 |
24 | MP0002136_abnormal_kidney_physiology | 1.60582938 |
25 | MP0002138_abnormal_hepatobiliary_system | 1.57639637 |
26 | MP0000537_abnormal_urethra_morphology | 1.55329583 |
27 | MP0001661_extended_life_span | 1.54952025 |
28 | MP0010234_abnormal_vibrissa_follicle | 1.53359115 |
29 | MP0001879_abnormal_lymphatic_vessel | 1.47851402 |
30 | MP0005319_abnormal_enzyme/_coenzyme | 1.45275484 |
31 | MP0005083_abnormal_biliary_tract | 1.44997472 |
32 | MP0000678_abnormal_parathyroid_gland | 1.43138527 |
33 | MP0001756_abnormal_urination | 1.39853132 |
34 | MP0004264_abnormal_extraembryonic_tissu | 1.38378384 |
35 | MP0000490_abnormal_crypts_of | 1.32672036 |
36 | MP0003879_abnormal_hair_cell | 1.32532757 |
37 | MP0005167_abnormal_blood-brain_barrier | 1.26854953 |
38 | MP0005084_abnormal_gallbladder_morpholo | 1.24239471 |
39 | MP0000230_abnormal_systemic_arterial | 1.23695018 |
40 | MP0000462_abnormal_digestive_system | 1.23172046 |
41 | MP0009384_cardiac_valve_regurgitation | 1.21763560 |
42 | MP0003195_calcinosis | 1.21623207 |
43 | MP0001501_abnormal_sleep_pattern | 1.20949439 |
44 | MP0003718_maternal_effect | 1.19707978 |
45 | MP0005451_abnormal_body_composition | 1.15829020 |
46 | MP0003183_abnormal_peptide_metabolism | 1.14304202 |
47 | MP0004858_abnormal_nervous_system | 1.14271760 |
48 | MP0005623_abnormal_meninges_morphology | 1.11859319 |
49 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.11387086 |
50 | MP0002135_abnormal_kidney_morphology | 1.08304716 |
51 | MP0003300_gastrointestinal_ulcer | 1.07613922 |
52 | MP0001188_hyperpigmentation | 1.01620847 |
53 | MP0005535_abnormal_body_temperature | 1.00137501 |
54 | MP0004043_abnormal_pH_regulation | 0.99279789 |
55 | MP0004782_abnormal_surfactant_physiolog | 0.97703522 |
56 | MP0001873_stomach_inflammation | 0.97180583 |
57 | MP0002822_catalepsy | 0.90491619 |
58 | MP0005670_abnormal_white_adipose | 0.88641745 |
59 | MP0009697_abnormal_copulation | 0.86635460 |
60 | MP0000598_abnormal_liver_morphology | 0.86222194 |
61 | MP0005666_abnormal_adipose_tissue | 0.86028903 |
62 | MP0003868_abnormal_feces_composition | 0.85974483 |
63 | MP0004185_abnormal_adipocyte_glucose | 0.85654705 |
64 | MP0001764_abnormal_homeostasis | 0.85333883 |
65 | MP0004084_abnormal_cardiac_muscle | 0.85142789 |
66 | MP0001663_abnormal_digestive_system | 0.82600949 |
67 | MP0004270_analgesia | 0.81293910 |
68 | MP0009642_abnormal_blood_homeostasis | 0.80781693 |
69 | MP0002254_reproductive_system_inflammat | 0.79840677 |
70 | MP0000477_abnormal_intestine_morphology | 0.78942092 |
71 | MP0005636_abnormal_mineral_homeostasis | 0.78541754 |
72 | MP0002796_impaired_skin_barrier | 0.77565478 |
73 | MP0002295_abnormal_pulmonary_circulatio | 0.77210698 |
74 | MP0005448_abnormal_energy_balance | 0.76572394 |
75 | MP0006138_congestive_heart_failure | 0.74146344 |
76 | MP0000604_amyloidosis | 0.73481520 |
77 | MP0004130_abnormal_muscle_cell | 0.73192604 |
78 | MP0002971_abnormal_brown_adipose | 0.73130349 |
79 | MP0001845_abnormal_inflammatory_respons | 0.72983697 |
80 | MP0001765_abnormal_ion_homeostasis | 0.70802022 |
81 | MP0006082_CNS_inflammation | 0.70497066 |
82 | MP0002876_abnormal_thyroid_physiology | 0.70195130 |
83 | MP0009053_abnormal_anal_canal | 0.70090811 |
84 | MP0008469_abnormal_protein_level | 0.70080502 |
85 | MP0009785_altered_susceptibility_to | 0.69058354 |
86 | MP0001485_abnormal_pinna_reflex | 0.68290423 |
87 | MP0002396_abnormal_hematopoietic_system | 0.68120952 |
88 | MP0008961_abnormal_basal_metabolism | 0.67900269 |
89 | MP0010352_gastrointestinal_tract_polyps | 0.66596146 |
90 | MP0004036_abnormal_muscle_relaxation | 0.66387544 |
91 | MP0005166_decreased_susceptibility_to | 0.65774954 |
92 | MP0000534_abnormal_ureter_morphology | 0.65499967 |
93 | MP0002896_abnormal_bone_mineralization | 0.64119447 |
94 | MP0000538_abnormal_urinary_bladder | 0.61717172 |
95 | MP0008872_abnormal_physiological_respon | 0.61328394 |
96 | MP0005375_adipose_tissue_phenotype | 0.60017852 |
97 | MP0003866_abnormal_defecation | 0.60002988 |
98 | MP0003724_increased_susceptibility_to | 0.59148378 |
99 | MP0005023_abnormal_wound_healing | 0.57915623 |
100 | MP0002078_abnormal_glucose_homeostasis | 0.57396043 |
101 | MP0005334_abnormal_fat_pad | 0.57085486 |
102 | MP0004147_increased_porphyrin_level | 0.55236445 |
103 | MP0003566_abnormal_cell_adhesion | 0.54289731 |
104 | MP0002128_abnormal_blood_circulation | 0.53358364 |
105 | MP0005377_hearing/vestibular/ear_phenot | 0.53164832 |
106 | MP0003878_abnormal_ear_physiology | 0.53164832 |
107 | MP0003115_abnormal_respiratory_system | 0.52223144 |
108 | MP0005381_digestive/alimentary_phenotyp | 0.52033589 |
109 | MP0001881_abnormal_mammary_gland | 0.51492653 |
110 | MP0009764_decreased_sensitivity_to | 0.51013921 |
111 | MP0009115_abnormal_fat_cell | 0.50592024 |
112 | MP0008775_abnormal_heart_ventricle | 0.49835163 |
113 | MP0002098_abnormal_vibrissa_morphology | 0.48998439 |
114 | MP0009763_increased_sensitivity_to | 0.47972348 |
115 | MP0005187_abnormal_penis_morphology | 0.47691621 |
116 | MP0004484_altered_response_of | 0.47449994 |
117 | MP0000579_abnormal_nail_morphology | 0.47151276 |
118 | MP0003953_abnormal_hormone_level | 0.47090450 |
119 | MP0000249_abnormal_blood_vessel | 0.46985627 |
120 | MP0003638_abnormal_response/metabolism_ | 0.46982739 |
121 | MP0000465_gastrointestinal_hemorrhage | 0.46754172 |
122 | MP0005501_abnormal_skin_physiology | 0.46458063 |
123 | MP0005376_homeostasis/metabolism_phenot | 0.46028706 |
124 | MP0000013_abnormal_adipose_tissue | 0.45763345 |
125 | MP0005503_abnormal_tendon_morphology | 0.45490567 |
126 | MP0010678_abnormal_skin_adnexa | 0.45314652 |
127 | MP0003656_abnormal_erythrocyte_physiolo | 0.45156613 |
128 | MP0000003_abnormal_adipose_tissue | 0.44283381 |
129 | MP0000516_abnormal_urinary_system | 0.43936200 |
130 | MP0005367_renal/urinary_system_phenotyp | 0.43421479 |
131 | MP0005395_other_phenotype | 0.42583634 |
132 | MP0002166_altered_tumor_susceptibility | 0.42237923 |
133 | MP0003329_amyloid_beta_deposits | 0.42105765 |
134 | MP0002998_abnormal_bone_remodeling | 0.41654721 |
135 | MP0005165_increased_susceptibility_to | 0.41186191 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Mesangial abnormality (HP:0001966) | 6.90678948 |
2 | Focal segmental glomerulosclerosis (HP:0000097) | 6.52343768 |
3 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 5.61199649 |
4 | Deep venous thrombosis (HP:0002625) | 5.42900967 |
5 | Glomerulosclerosis (HP:0000096) | 5.35289751 |
6 | Hypobetalipoproteinemia (HP:0003563) | 5.32599484 |
7 | Chronic diarrhea (HP:0002028) | 5.11343678 |
8 | Abnormality of the vitamin B12 metabolism (HP:0004341) | 5.05268366 |
9 | Xanthomatosis (HP:0000991) | 4.83543431 |
10 | Hypoalbuminemia (HP:0003073) | 4.76811833 |
11 | Abnormal albumin level (HP:0012116) | 4.76811833 |
12 | Intrahepatic cholestasis (HP:0001406) | 4.72179445 |
13 | Abnormality of vitamin B metabolism (HP:0004340) | 4.70876375 |
14 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.62405951 |
15 | Nephritis (HP:0000123) | 4.47921404 |
16 | Glomerulonephritis (HP:0000099) | 4.37875765 |
17 | Confusion (HP:0001289) | 4.35018879 |
18 | Systemic lupus erythematosus (HP:0002725) | 4.21142733 |
19 | Hydroxyprolinuria (HP:0003080) | 4.06956450 |
20 | Abnormality of proline metabolism (HP:0010907) | 4.06956450 |
21 | Hyperglycinuria (HP:0003108) | 4.00629104 |
22 | Hypolipoproteinemia (HP:0010981) | 3.77115726 |
23 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 3.72905081 |
24 | Conjugated hyperbilirubinemia (HP:0002908) | 3.71063161 |
25 | Nausea (HP:0002018) | 3.64248380 |
26 | Fat malabsorption (HP:0002630) | 3.62812121 |
27 | Wide cranial sutures (HP:0010537) | 3.55288466 |
28 | Hyperlipoproteinemia (HP:0010980) | 3.44551720 |
29 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 3.43945547 |
30 | Ileus (HP:0002595) | 3.43885665 |
31 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.42612531 |
32 | Abnormality of glycine metabolism (HP:0010895) | 3.42612531 |
33 | Autoimmune thrombocytopenia (HP:0001973) | 3.30732645 |
34 | Acanthocytosis (HP:0001927) | 3.30207297 |
35 | Thin bony cortex (HP:0002753) | 3.29336414 |
36 | Epidermoid cyst (HP:0200040) | 3.25647073 |
37 | Hyperammonemia (HP:0001987) | 3.21581331 |
38 | Malnutrition (HP:0004395) | 3.19479391 |
39 | Prolonged partial thromboplastin time (HP:0003645) | 3.14768485 |
40 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.14404921 |
41 | Polycythemia (HP:0001901) | 3.09636418 |
42 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.08216883 |
43 | Potter facies (HP:0002009) | 3.04601887 |
44 | Facial shape deformation (HP:0011334) | 3.04601887 |
45 | Abnormality of purine metabolism (HP:0004352) | 3.03832753 |
46 | Megaloblastic anemia (HP:0001889) | 3.00375501 |
47 | Hypercholesterolemia (HP:0003124) | 2.94279894 |
48 | Complement deficiency (HP:0004431) | 2.92870641 |
49 | Metabolic alkalosis (HP:0200114) | 2.92075875 |
50 | Congenital sensorineural hearing impairment (HP:0008527) | 2.85605291 |
51 | Posterior subcapsular cataract (HP:0007787) | 2.84688375 |
52 | Gout (HP:0001997) | 2.82012483 |
53 | Abnormality of the common coagulation pathway (HP:0010990) | 2.80721245 |
54 | Decreased circulating renin level (HP:0003351) | 2.79241350 |
55 | Abnormal urine phosphate concentration (HP:0012599) | 2.78946493 |
56 | Ketosis (HP:0001946) | 2.77178340 |
57 | Stage 5 chronic kidney disease (HP:0003774) | 2.75739672 |
58 | Hypoglycemic coma (HP:0001325) | 2.75593398 |
59 | Hypoalphalipoproteinemia (HP:0003233) | 2.73600525 |
60 | Abnormality of nucleobase metabolism (HP:0010932) | 2.65321204 |
61 | Hyperglycinemia (HP:0002154) | 2.57367520 |
62 | Right ventricular cardiomyopathy (HP:0011663) | 2.54517138 |
63 | Esophageal varix (HP:0002040) | 2.48800470 |
64 | Abnormality of renin-angiotensin system (HP:0000847) | 2.47966892 |
65 | Enlarged epiphyses (HP:0010580) | 2.47720385 |
66 | Abnormal tarsal ossification (HP:0008369) | 2.46756305 |
67 | Ketoacidosis (HP:0001993) | 2.43053418 |
68 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.40896045 |
69 | Delayed epiphyseal ossification (HP:0002663) | 2.40593216 |
70 | Abdominal distention (HP:0003270) | 2.38842958 |
71 | Abnormality of the intrinsic pathway (HP:0010989) | 2.38447443 |
72 | Lymphangioma (HP:0100764) | 2.38370268 |
73 | Pigmentary retinal degeneration (HP:0001146) | 2.37967198 |
74 | Abnormal glucose tolerance (HP:0001952) | 2.37177961 |
75 | Vascular calcification (HP:0004934) | 2.35003354 |
76 | Abnormality of magnesium homeostasis (HP:0004921) | 2.34751249 |
77 | Proteinuria (HP:0000093) | 2.34227926 |
78 | Hemorrhage of the eye (HP:0011885) | 2.33592274 |
79 | Joint hemorrhage (HP:0005261) | 2.32803490 |
80 | Tubulointerstitial fibrosis (HP:0005576) | 2.30835222 |
81 | Hypotension (HP:0002615) | 2.30518761 |
82 | Hyperparathyroidism (HP:0000843) | 2.29375141 |
83 | Hypoproteinemia (HP:0003075) | 2.28550467 |
84 | Abnormality of small intestinal villus morphology (HP:0011472) | 2.25726336 |
85 | Villous atrophy (HP:0011473) | 2.25726336 |
86 | Hypophosphatemia (HP:0002148) | 2.24409773 |
87 | Visceral angiomatosis (HP:0100761) | 2.24386922 |
88 | Abnormality of the costochondral junction (HP:0000919) | 2.23881018 |
89 | Nephrotic syndrome (HP:0000100) | 2.22171791 |
90 | Renal tubular acidosis (HP:0001947) | 2.21749645 |
91 | Subcapsular cataract (HP:0000523) | 2.18407073 |
92 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.17860346 |
93 | Metabolic acidosis (HP:0001942) | 2.17774024 |
94 | Cardiovascular calcification (HP:0011915) | 2.16383177 |
95 | Neonatal respiratory distress (HP:0002643) | 2.16045566 |
96 | Hyperbilirubinemia (HP:0002904) | 2.15909755 |
97 | Sensorimotor neuropathy (HP:0007141) | 2.15875098 |
98 | Tubular atrophy (HP:0000092) | 2.13749382 |
99 | Nephrolithiasis (HP:0000787) | 2.13490513 |
100 | Skin nodule (HP:0200036) | 2.13417306 |
101 | Eczematoid dermatitis (HP:0000976) | 2.11562284 |
102 | Hyperphosphatemia (HP:0002905) | 2.09315660 |
103 | Interstitial pulmonary disease (HP:0006530) | 2.07785437 |
104 | Hematuria (HP:0000790) | 2.06412842 |
105 | Cerebral palsy (HP:0100021) | 2.06277091 |
106 | Hemangiomatosis (HP:0007461) | 2.05094202 |
107 | Corneal erosion (HP:0200020) | 2.03950088 |
108 | Protuberant abdomen (HP:0001538) | 2.03940360 |
109 | Myocardial infarction (HP:0001658) | 2.02747804 |
110 | Abnormality of complement system (HP:0005339) | 2.01516608 |
111 | Hyperactive renin-angiotensin system (HP:0000841) | 2.00936490 |
112 | Metaphyseal cupping (HP:0003021) | 2.00086776 |
113 | Pancreatitis (HP:0001733) | 1.98030397 |
114 | Glycosuria (HP:0003076) | 1.97355944 |
115 | Abnormality of urine glucose concentration (HP:0011016) | 1.97355944 |
116 | Poikilocytosis (HP:0004447) | 1.95822798 |
117 | Increased purine levels (HP:0004368) | 1.92633235 |
118 | Hyperuricemia (HP:0002149) | 1.92633235 |
119 | Renal tubular dysfunction (HP:0000124) | 1.92353431 |
120 | Alkalosis (HP:0001948) | 1.90759271 |
121 | Late onset (HP:0003584) | 1.89913499 |
122 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.89345863 |
123 | Proximal tubulopathy (HP:0000114) | 1.89263872 |
124 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.89123236 |
125 | Abnormality of pyrimidine metabolism (HP:0004353) | 1.88298106 |
126 | Chorioretinal atrophy (HP:0000533) | 1.88180690 |
127 | Irritability (HP:0000737) | 1.87882087 |
128 | Steatorrhea (HP:0002570) | 1.87664110 |
129 | Delayed CNS myelination (HP:0002188) | 1.83332915 |
130 | Widely patent fontanelles and sutures (HP:0004492) | 1.82849348 |
131 | Hepatocellular carcinoma (HP:0001402) | 1.82223918 |
132 | Osteomalacia (HP:0002749) | 1.81180240 |
133 | Amyloidosis (HP:0011034) | 1.80878705 |
134 | Rickets (HP:0002748) | 1.80224173 |
135 | Increased circulating renin level (HP:0000848) | 1.78269088 |
136 | Hypophosphatemic rickets (HP:0004912) | 1.75581221 |
137 | Hypokalemia (HP:0002900) | 1.75578539 |
138 | Chondrocalcinosis (HP:0000934) | 1.75345887 |
139 | Polar cataract (HP:0010696) | 1.74939261 |
140 | Gingivitis (HP:0000230) | 1.74571363 |
141 | Abnormality of methionine metabolism (HP:0010901) | 1.72141510 |
142 | Abnormality of vitamin metabolism (HP:0100508) | 1.71996802 |
143 | Hyperphosphaturia (HP:0003109) | 1.71956523 |
144 | Growth hormone excess (HP:0000845) | 1.71026707 |
145 | Generalized aminoaciduria (HP:0002909) | 1.70768885 |
146 | Gastrointestinal dysmotility (HP:0002579) | 1.69904833 |
147 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.69647750 |
148 | Dicarboxylic aciduria (HP:0003215) | 1.69647750 |
149 | Dehydration (HP:0001944) | 1.64253173 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ACVR1B | 7.99425964 |
2 | FRK | 3.77057273 |
3 | EPHB2 | 3.61219124 |
4 | ERN1 | 3.36582106 |
5 | TIE1 | 2.90573470 |
6 | MST4 | 2.83799304 |
7 | EPHA2 | 2.75810734 |
8 | FGFR4 | 2.73067075 |
9 | MST1R | 2.52330285 |
10 | WNK4 | 2.48399449 |
11 | SIK1 | 2.43825486 |
12 | MYLK | 2.37685415 |
13 | TRIB3 | 2.34492328 |
14 | KDR | 2.27956206 |
15 | PAK4 | 2.22065689 |
16 | BCKDK | 2.19320364 |
17 | RIPK1 | 2.18591968 |
18 | TGFBR2 | 2.06909446 |
19 | PTK6 | 2.01650198 |
20 | LATS1 | 2.01031455 |
21 | TNIK | 1.98790186 |
22 | AKT3 | 1.90044884 |
23 | OXSR1 | 1.88165832 |
24 | MAP3K10 | 1.85281166 |
25 | GRK6 | 1.82853557 |
26 | MAP3K12 | 1.76150974 |
27 | EPHB1 | 1.72504942 |
28 | LMTK2 | 1.60947023 |
29 | FGFR2 | 1.53819733 |
30 | CAMK1D | 1.43770549 |
31 | MAP3K7 | 1.41399545 |
32 | PRKG2 | 1.40033164 |
33 | PDGFRA | 1.35228119 |
34 | NME1 | 1.34183854 |
35 | STK39 | 1.25411870 |
36 | NLK | 1.21806140 |
37 | LRRK2 | 1.19820098 |
38 | MET | 1.17338842 |
39 | TAOK3 | 1.15500677 |
40 | MAP2K2 | 1.14262376 |
41 | TESK2 | 1.11416112 |
42 | PKN2 | 1.11107235 |
43 | TYK2 | 1.10681522 |
44 | STK10 | 1.07396228 |
45 | INSRR | 1.07193934 |
46 | FER | 1.06452795 |
47 | TGFBR1 | 1.01868355 |
48 | MATK | 0.98094186 |
49 | MAPK11 | 0.97296135 |
50 | MAP3K2 | 0.95787135 |
51 | CASK | 0.93801653 |
52 | EPHA4 | 0.91794781 |
53 | CAMK1G | 0.89972118 |
54 | PRKAA2 | 0.89411990 |
55 | GSK3A | 0.89164999 |
56 | PTK2 | 0.88637568 |
57 | MAP2K1 | 0.87605920 |
58 | MAP2K6 | 0.86659324 |
59 | NEK9 | 0.85705849 |
60 | MAP3K3 | 0.85692370 |
61 | STK24 | 0.84226339 |
62 | FGFR3 | 0.83373598 |
63 | PAK2 | 0.72851482 |
64 | JAK1 | 0.72056035 |
65 | EPHA3 | 0.71016801 |
66 | ABL2 | 0.70342230 |
67 | PRPF4B | 0.70261572 |
68 | CDC42BPA | 0.69507725 |
69 | PDPK1 | 0.69225221 |
70 | MAP4K1 | 0.69071563 |
71 | PDK2 | 0.67012529 |
72 | BMX | 0.66873223 |
73 | TESK1 | 0.65222607 |
74 | PAK3 | 0.64670063 |
75 | JAK2 | 0.63907404 |
76 | STK3 | 0.61694932 |
77 | NUAK1 | 0.61694749 |
78 | PIM1 | 0.60898416 |
79 | TBK1 | 0.60335498 |
80 | PRKCA | 0.59567459 |
81 | BCR | 0.58957126 |
82 | PRKAA1 | 0.58730054 |
83 | MAP2K3 | 0.58520338 |
84 | GRK1 | 0.58369399 |
85 | PRKCZ | 0.57545600 |
86 | ROCK1 | 0.55622012 |
87 | STK38L | 0.54380892 |
88 | ERBB2 | 0.54036373 |
89 | PIK3CG | 0.53287097 |
90 | PDGFRB | 0.52242900 |
91 | RET | 0.51274170 |
92 | BMPR2 | 0.50852492 |
93 | CDK6 | 0.50362400 |
94 | CAMK2B | 0.49904005 |
95 | ERBB4 | 0.49159998 |
96 | MAPK15 | 0.49018249 |
97 | DYRK1B | 0.47402137 |
98 | CSK | 0.46381090 |
99 | MTOR | 0.46318713 |
100 | SGK3 | 0.44516599 |
101 | PRKACG | 0.44313361 |
102 | IRAK1 | 0.41439709 |
103 | DAPK2 | 0.41078654 |
104 | NEK6 | 0.40835596 |
105 | MELK | 0.40508403 |
106 | MAP3K8 | 0.40308885 |
107 | PDK3 | 0.40129059 |
108 | PDK4 | 0.40129059 |
109 | MAP3K11 | 0.39798632 |
110 | ZAP70 | 0.39765974 |
111 | PRKCD | 0.39655566 |
112 | MAPK4 | 0.39441982 |
113 | CAMK2D | 0.39168910 |
114 | CAMK2G | 0.39081907 |
115 | TAOK1 | 0.38927781 |
116 | PIK3CA | 0.38646220 |
117 | DDR2 | 0.38306014 |
118 | IGF1R | 0.37590898 |
119 | CSF1R | 0.36093549 |
120 | PDK1 | 0.35915964 |
121 | FGFR1 | 0.35065702 |
122 | RIPK4 | 0.34187881 |
123 | FLT3 | 0.32908380 |
124 | NTRK1 | 0.32528983 |
125 | PRKD1 | 0.32294956 |
126 | MAP3K1 | 0.31829930 |
127 | MAPK7 | 0.30444083 |
128 | MAPK12 | 0.30434099 |
129 | KSR2 | 0.30368052 |
130 | FYN | 0.29969564 |
131 | SRC | 0.29942309 |
132 | PRKCI | 0.28043515 |
133 | YES1 | 0.27401442 |
134 | KIT | 0.25488309 |
135 | ITK | 0.24746028 |
136 | OBSCN | 0.22100599 |
137 | MAPKAPK2 | 0.21699310 |
138 | MAP3K14 | 0.20872924 |
139 | PRKACA | 0.20863777 |
140 | TEC | 0.19176551 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Fat digestion and absorption_Homo sapiens_hsa04975 | 3.19250855 |
2 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.12976741 |
3 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.98664232 |
4 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.88097926 |
5 | Caffeine metabolism_Homo sapiens_hsa00232 | 2.56485773 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.48651300 |
7 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.43900682 |
8 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 2.38529777 |
9 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.36288280 |
10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.19679173 |
11 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.08135449 |
12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.05993451 |
13 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 2.04854473 |
14 | Bile secretion_Homo sapiens_hsa04976 | 2.04716282 |
15 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 2.04492428 |
16 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.03885560 |
17 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 2.02173134 |
18 | Histidine metabolism_Homo sapiens_hsa00340 | 1.97834091 |
19 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.96463804 |
20 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.89249666 |
21 | * Renin-angiotensin system_Homo sapiens_hsa04614 | 1.84384061 |
22 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.78172042 |
23 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.75052007 |
24 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.68524687 |
25 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.65381107 |
26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.64811662 |
27 | Peroxisome_Homo sapiens_hsa04146 | 1.64795911 |
28 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.63517605 |
29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.63180561 |
30 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.60843666 |
31 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.59329660 |
32 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.58953157 |
33 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.58899259 |
34 | Mineral absorption_Homo sapiens_hsa04978 | 1.54023725 |
35 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.53555543 |
36 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.52053905 |
37 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.50354367 |
38 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.47456783 |
39 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 1.43649959 |
40 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.39950670 |
41 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.37354069 |
42 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.34863896 |
43 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.31588551 |
44 | ABC transporters_Homo sapiens_hsa02010 | 1.30440806 |
45 | Galactose metabolism_Homo sapiens_hsa00052 | 1.24673826 |
46 | Retinol metabolism_Homo sapiens_hsa00830 | 1.24145574 |
47 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 1.22992014 |
48 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.19077728 |
49 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.14685119 |
50 | Carbon metabolism_Homo sapiens_hsa01200 | 1.07392087 |
51 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 1.04859958 |
52 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.04073294 |
53 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.00242641 |
54 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.00224537 |
55 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.98316414 |
56 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.96348771 |
57 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.95302934 |
58 | Lysine degradation_Homo sapiens_hsa00310 | 0.92494079 |
59 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.91847278 |
60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.88925754 |
61 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.83765985 |
62 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.83413019 |
63 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.83392028 |
64 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79824051 |
65 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78900486 |
66 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.77328139 |
67 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.76502316 |
68 | Asthma_Homo sapiens_hsa05310 | 0.75914881 |
69 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.75532382 |
70 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.73694797 |
71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.73269491 |
72 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.63849534 |
73 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.63235407 |
74 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.54406309 |
75 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.52229728 |
76 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.51920517 |
77 | Allograft rejection_Homo sapiens_hsa05330 | 0.50506733 |
78 | Amoebiasis_Homo sapiens_hsa05146 | 0.49792872 |
79 | Insulin resistance_Homo sapiens_hsa04931 | 0.48598294 |
80 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.46961744 |
81 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.46570742 |
82 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.45528368 |
83 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.44795722 |
84 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.43411634 |
85 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41627900 |
86 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.39036170 |
87 | Sulfur relay system_Homo sapiens_hsa04122 | 0.38580056 |
88 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.35973344 |
89 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.35926553 |
90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.35513380 |
91 | Focal adhesion_Homo sapiens_hsa04510 | 0.33864012 |
92 | Renin secretion_Homo sapiens_hsa04924 | 0.33363940 |
93 | Other glycan degradation_Homo sapiens_hsa00511 | 0.32161423 |
94 | Metabolic pathways_Homo sapiens_hsa01100 | 0.31793974 |
95 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.28460141 |
96 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.23791689 |
97 | Tight junction_Homo sapiens_hsa04530 | 0.23660840 |
98 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.23437132 |
99 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.21822794 |
100 | Bladder cancer_Homo sapiens_hsa05219 | 0.20008742 |
101 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.19121730 |
102 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.19053558 |
103 | Adherens junction_Homo sapiens_hsa04520 | 0.18676161 |
104 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.17071361 |
105 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.16607287 |
106 | Cocaine addiction_Homo sapiens_hsa05030 | 0.15817835 |
107 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.15465729 |
108 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.14689342 |
109 | Pertussis_Homo sapiens_hsa05133 | 0.12762916 |
110 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.11533267 |
111 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.10782395 |
112 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.10683169 |
113 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.10471193 |
114 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.08589850 |
115 | Hepatitis C_Homo sapiens_hsa05160 | 0.08281719 |
116 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.06844152 |
117 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.05953628 |
118 | Insulin secretion_Homo sapiens_hsa04911 | 0.05233802 |
119 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.02651552 |
120 | Leishmaniasis_Homo sapiens_hsa05140 | 0.01832172 |
121 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.01556843 |
122 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.01434536 |
123 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.01360482 |
124 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.01008679 |